MANE · Veradermics, Inc
$112.71
+1.71 (+1.54%)
At close · Aug 14
Going-concern doubt
— cleared Aug 11, 2026
The latest filing no longer states the doubt (first flagged May 12, 2026).
View the 10-Q filed Aug 11, 2026Market Cap
$4.71B
Shares
41.78M
Veradermics, Inc Earnings Call Transcripts
Every quarterly earnings call for Veradermics, Inc (MANE) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY26 · Q2
2026-08-11
Earnings conference call (announced in 8-K)
Confident tone
Study 207 female Phase II results
Pivotal trial outlook (Study 306)
VDPHL01 product profile (extended-release oral minoxidil)
Diluted EPS
$-0.58
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-04-27
Veradermics, Inc Q4 FY2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–4 of 4 earnings calls
Key facts
CIK
1827635
CUSIP
922967104
13F (30d)
162 filings
161 filers
Visit website
Investor relations